Honor Education | $38,000,000 | (Jul 9, 2025)
Sundial | $16,000,000 | (Jul 9, 2025)
Tulum Energy | $27,000,000 | (Jul 9, 2025)
Actithera
Norway
- Oslo
- 09/07/2025
- Series A
- $75,500,000
Actithera is a radiopharmaceutical biotech company translating medicinal chemistry insights into next-generation radioligand therapies (RLTs). Founded in 2021 by drug discovery innovator Dr. Andreas Goutopoulos, and seed investors M Ventures, and Arkin Bio Ventures II, Actithera applies various molecular design strategies, including covalent-targeting and an isotope-agnostic philosophy to invent RLTs with significant differentiation and larger therapeutic windows. Headquartered in Oslo, Norway, and Cambridge, Massachusetts, Actithera is committed to advancing a differentiated pipeline addressing critical unmet needs in oncology.
- Industry Biotechnology Research
- Website https://actithera.com/
- LinkedIn https://www.linkedin.com/company/actithera/
Related People
Andreas GoutopoulosFounder
United States -
Boston, Massachusetts
Founder of Actithera, developing smarter radiopharmaceuticals to treat cancer more effectively and safely. Focused on turning chemistry and science into better outcomes for patients.
AppsForBharat | $20,000,000 | (Jul 9, 2025)
Belong - NRI savings & investments | $5,000,000 | (Jul 9, 2025)
Brainfish | $6,400,000 | (Jul 9, 2025)
BridgePort(US) | $3,200,000 | (Jul 9, 2025)
OllyGarden | $1,600,000 | (Jul 9, 2025)
Restore Medical | $23,000,000 | (Jul 9, 2025)
Dexter Energy | $26,954,177 | (Jul 9, 2025)
Centivax | $45,000,000 | (Jul 9, 2025)